Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

IMMX

Immix Biopharma Inc

May 11 • 10:42AM ET

9.80

+0.05 0.51 %

Healthcare • Biotechnology • USA • Small • NASD

Peers: COGT NUVB CCCC KURA FATE

| Held by: VTI VXF IWC AVSC

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-0.92	Insider Own	24.92%	Shs Outstand	53.01M	Perf Week	3.38%
Market Cap	533.23M	Forward P/E	-	EPS next Y	-0.68	Insider Trans	0.01%	Shs Float	40.85M	Perf Month	5.83%
Enterprise Value	443.69M	PEG	-	EPS next Q	-0.18	Inst Own	46.99%	Short Float	7.25%	Perf Quarter	52.65%
Income	-34.98M	P/S	-	EPS this Y	16.81%	Inst Trans	68.01%	Short Ratio	3.80	Perf Half Y	223.43%
Sales	0.00M	P/B	6.16	EPS next Y	8.83%	ROA	-60.47%	Short Interest	2.96M	Perf YTD	87.38%
Book/sh	1.59	P/C	5.89	EPS next 5Y	42.79%	ROE	-74.47%	52W High	11.61 -15.59%	Perf Year	368.90%
Cash/sh	1.66	P/FCF	-	EPS past 3/5Y	-12.81% -43.32%	ROIC	-41.02%	52W Low	1.87 424.06%	Perf 3Y	347.49%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	9.41% 7.78%	Perf 5Y	-
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	-27.17%	Oper. Margin	-	ATR (14)	0.76	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	8.76	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	53.47	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	8.76	EPS Q/Q	-19.16%	SMA20	1.23%	Beta	0.13	Target Price	18.25
Payout	-	Debt/Eq	0.01	Sales Q/Q	-	SMA50	3.97%	Rel Volume	0.93	Prev Close	9.75
Employees	21	LT Debt/Eq	0.01	Earnings	Feb 25	SMA200	80.70%	Avg Volume	780.15K	Price	9.80
IPO	Dec 16, 2021	Option/Short	Yes / Yes	EPS/Sales Surpr.	-83.03% -	Trades		Volume	163,224	Change	0.51%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)